These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2113967)

  • 1. Neuroendocrinological effects of L-threo-3, 4-dihydroxyphenylserine (DOPS), a putative norepinephrine precursor, on healthy volunteers.
    Semba J; Nankai M; Okubo Y; Kato M; Matsuura M; Takahashi R
    Jpn J Psychiatry Neurol; 1990 Mar; 44(1):73-8. PubMed ID: 2113967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
    Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J; Takahashi R
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
    Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
    Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD; Cilmi KM; Mattis-Graves K
    Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in norepinephrine turnover after tyrosine or DL-threo-3,4-dihydroxyphenylserine (DL-threo-DOPS).
    Gibson CJ
    Life Sci; 1988; 42(1):95-102. PubMed ID: 3121971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S
    Life Sci; 1985 Feb; 36(5):435-42. PubMed ID: 3918223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine.
    Naoi M; Nagatsu T
    J Neurochem; 1986 Aug; 47(2):604-7. PubMed ID: 3090204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.